SAB Biotherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SABS and other ETFs, options, and stocks.About SABS
SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company, which engages in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases.
CEOSamuel J. Reich
CEOSamuel J. Reich
Employees63
Employees63
HeadquartersMiami Beach, Florida
HeadquartersMiami Beach, Florida
Founded2014
Founded2014
Employees63
Employees63
SABS Key Statistics
Market cap200.36M
Market cap200.36M
Price-Earnings ratio-1.28
Price-Earnings ratio-1.28
Dividend yield—
Dividend yield—
Average volume347.92K
Average volume347.92K
High today$4.01
High today$4.01
Low today$3.82
Low today$3.82
Open price$3.93
Open price$3.93
Volume778.19K
Volume778.19K
52 Week high$6.60
52 Week high$6.60
52 Week low$1.00
52 Week low$1.00
Stock Snapshot
SAB Biotherapeutics(SABS) stock is priced at $4.00, giving the company a market capitalization of 200.36M. It carries a P/E multiple of -1.28.
On 2026-01-14, SAB Biotherapeutics(SABS) stock traded between a low of $3.82 and a high of $4.01. Shares are currently priced at $4.00, which is +4.7% above the low and -0.1% below the high.
SAB Biotherapeutics(SABS) shares are trading with a volume of 778.19K, against a daily average of 347.92K.
During the past year, SAB Biotherapeutics(SABS) stock moved between $1.00 at its lowest and $6.60 at its peak.
During the past year, SAB Biotherapeutics(SABS) stock moved between $1.00 at its lowest and $6.60 at its peak.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own SABS. This list is generated using Robinhood data, and it’s not a recommendation.